Biogen's most recent trend suggests a bullish bias. One trading opportunity on Biogen is a Bull Put Spread using a strike $235.00 short put and a strike $230.00 long put offers a potential 16.28% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $235.00 by expiration. The full premium credit of $0.70 would be kept by the premium seller. The risk of $4.30 would be incurred if the stock dropped below the $230.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Biogen is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Biogen is bullish.
The RSI indicator is at 22.27 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Biogen
Sarissa Capital Management Hires New President
Mon, 08 Apr 2019 03:59:13 +0000
Sarissa Capital Management was one of those rare activist hedge funds, which managed to beat the last year’s tough market environment, returning 15.5%. Just for the comparison, an average activist hedge fund reported a loss of 11% in the same period, and the S&P 500 lost 4.4%. Even over the last three years, the fund […]
Should Biogen Investors Be Extra Nervous Right Now?
Sat, 06 Apr 2019 22:13:00 +0000
The biotech giant's most important drug is under a microscope and it doesn't look pretty.
Here's What Biogen Inc.'s (NASDAQ:BIIB) P/E Ratio Is Telling Us
Thu, 04 Apr 2019 19:54:01 +0000
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it prac…
1 Biotech That Biogen Should Buy … but Probably Won't
Thu, 04 Apr 2019 18:49:00 +0000
The drugmaker has $4.9 billion in the bank.
Buy Biogen on the dip? What about AMC on the streaming wars? The viewers #AskHalftime
Thu, 04 Apr 2019 17:28:08 +0000
The "Halftime Report" traders answer viewer questions on Biogen and AMC
Also on Market Tamer…
Follow Us on Facebook